Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gast... Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales. Show more
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation System PR Newswire MARLBOROUGH, Mass., Sept. 27, 2024 MARLBOROUGH, Mass., Sept. 27, 2024...
Boston Scientific Closes Acquisition of Silk Road Medical, Inc. PR Newswire MARLBOROUGH, Mass., Sept. 17, 2024 MARLBOROUGH, Mass., Sept. 17, 2024 /PRNewswire/ -- Boston Scientific Corporation...
Boston Scientific Receives FDA Approval for Expanded Indication of INGEVITY™+ Pacing Leads to Include Conduction System Pacing of the Left Bundle Branch Area PR Newswire MARLBOROUGH, Mass., Sept...
Boston Scientific Obtains CE Mark for ACURATE Prime™ Aortic Valve System PR Newswire MARLBOROUGH, Mass., Aug. 27, 2024 MARLBOROUGH, Mass., Aug. 27, 2024 /PRNewswire/ -- Boston Scientific...
Boston Scientific to Participate in Wells Fargo's 2024 Healthcare Conference PR Newswire MARLBOROUGH, Mass., Aug. 13, 2024 MARLBOROUGH, Mass., Aug. 13, 2024 /PRNewswire/ -- Boston Scientific...
Boston Scientific Elects David Habiger to Board of Directors PR Newswire MARLBOROUGH, Mass., July 30, 2024 MARLBOROUGH, Mass., July 30, 2024 /PRNewswire/ -- Boston Scientific Corporation...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass., July 24, 2024 MARLBOROUGH, Mass., July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE:...
Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results PR Newswire MARLBOROUGH, Mass., July 1, 2024 MARLBOROUGH, Mass., July 1, 2024 /PRNewswire/ -- Boston Scientific...
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Silk Road Medical, Inc. PR Newswire NEW YORK, June 18, 2024 NEW YORK, June 18, 2024 /PRNewswire/ -- Rowley Law PLLC is...
Boston Scientific to acquire Silk Road Medical for $27.50 per share in cash SUNNYVALE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (“Silk Road”) (NASDAQ:SILK), a leading...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.21 | -0.251316419339 | 83.56 | 84.71 | 82.59 | 5009354 | 83.66361293 | CS |
| 4 | 2.52 | 3.11765433626 | 80.83 | 84.89 | 80.5 | 5377041 | 82.82579443 | CS |
| 12 | 6.79 | 8.86886102403 | 76.56 | 84.89 | 71.88 | 5546965 | 78.51968875 | CS |
| 26 | 15.18 | 22.2678597624 | 68.17 | 84.89 | 66.8 | 5746819 | 75.48645527 | CS |
| 52 | 30.57 | 57.9196665404 | 52.78 | 84.89 | 48.35 | 6381749 | 65.80829927 | CS |
| 156 | 38.46 | 85.6760971263 | 44.89 | 84.89 | 34.98 | 7381186 | 51.05529042 | CS |
| 260 | 40.9 | 96.3486454653 | 42.45 | 84.89 | 24.1 | 8147780 | 45.21642538 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
